Fact Sheet: The United States, Switzerland, and Liechtenstein Reach a Historic Trade Deal

The United States has announced a framework for a new trade deal with Switzerland and Liechtenstein, aiming to significantly reduce the U.S. trade deficit, which stood at $38.5 billion in 2024, with a target for elimination by 2028. This agreement is projected to secure over $200 billion in investment commitments from Swiss and Liechtenstein companies, including at least $67 billion by 2026, creating thousands of U.S. jobs across various sectors. Key provisions include expanded market access for U.S. agricultural and industrial exports, removal of tariffs and non-tariff barriers, and commitments on intellectual property and digital trade, with negotiations targeted for conclusion in early 2026.

Analysis

The United States has announced a framework for a historic trade deal with Switzerland and Liechtenstein, targeting the elimination of the $38.5 billion U.S. goods trade deficit by 2028. This agreement is projected to attract over $200 billion in investment commitments from Swiss and Liechtenstein companies, with at least $67 billion anticipated by 2026. The deal aims to create thousands of American jobs across diverse sectors, underscoring a significant economic boost.

Key provisions include unprecedented access for U.S. exporters to Swiss and Liechtenstein markets, particularly for agricultural products like poultry, bison, and beef, alongside industrial goods. Major Swiss companies such as Roche, Novartis, ABB, and Stadler have already announced investments, benefiting sectors like pharmaceuticals, medical devices, aerospace, and advanced manufacturing. The framework also addresses the removal of tariffs on various goods and non-tariff barriers that previously hindered U.S. exports.

Beyond market access, the agreement incorporates robust commitments on intellectual property rights, digital trade principles (including refraining from harmful digital services taxes), and enhanced cooperation on supply chain resilience. It also seeks to streamline customs processes and address restrictive measures on U.S. poultry and dairy products. Negotiations are slated for conclusion in early 2026, aiming to solidify these benefits and establish a more balanced trade relationship.

Key Decisions for Investors

• Investors should evaluate U.S. companies in sectors poised for growth due to Swiss/Liechtenstein investment, such as pharmaceuticals, medical devices, aerospace, and advanced manufacturing.
• Monitor the progress of the trade deal negotiations, particularly the finalization timeline in early 2026, for specific tariff reductions and non-tariff barrier removals impacting U.S. exporters.
• Assess potential impacts on global supply chains and intellectual property protection for companies operating in or with exposure to the U.S., Switzerland, and Liechtenstein markets.
• Consider the implications for companies like Novartis (NVS) which have already committed to significant U.S. investments, as their strategic positioning may be enhanced by this framework.